Halozyme
The Manager, Strategy & Insights at Halozyme is a strategic role focused on shaping the company’s long-term growth through market and competitive insight and by supporting corporate development decisions. The position partners with executive leadership to enable data-driven planning and investment prioritization.
Halozyme is a biopharmaceutical company focused on reinventing the patient experience through innovative drug delivery technologies. The company develops its proprietary ENHANZE® platform, auto-injector, and multi-dose pen technologies to ease the burden of treatment and improve patient outcomes. Halozyme partners with pharmaceutical companies and maintains a robust commercial product portfolio in the drug delivery industry.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Halozyme.
Capital Fund Management S.A. Has $15.60 Million Stake in Halozyme Therapeutics, Inc. $HALO
18 hours ago